The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence

International Journal of Geriatric Psychiatry - Tập 18 Số S1 - Trang S23-S32 - 2003
Wojciech Danysz1, Chris G. Parsons1
1Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

Albin, 1992, Neurology, 42, 733, 10.1212/WNL.42.4.733

Bachurin, 2001, Ann N Y Acad Sci, 939, 219, 10.1111/j.1749-6632.2001.tb03629.x

Barnes, 1996, Eur J Neurosci, 8, 565, 10.1111/j.1460-9568.1996.tb01241.x

Braak, 1993, Eur Neurol, 33, 403, 10.1159/000116984

Brorson, 1995, J Neurobiol, 26, 325, 10.1002/neu.480260305

Clements, 1992, Science, 258, 1498, 10.1126/science.1359647

Cullen, 1996, Neuroreport, 8, 87, 10.1097/00001756-199612200-00018

Danysz, 2000, Neurotox Res, 2, 85, 10.1007/BF03033787

Ferrarese, 2000, Ann Neurol, 47, 641, 10.1002/1531-8249(200005)47:5<641::AID-ANA12>3.0.CO;2-I

Francis, 1993, J Neurochem, 60, 1589, 10.1111/j.1471-4159.1993.tb13381.x

Frankiewicz, 1999, Neuropharmacol, 38, 1253, 10.1016/S0028-3908(99)00060-X

Giulian, 1995, Neurochem Int, 27, 119, 10.1016/0197-0186(95)00067-I

Greenamyre, 1986, Arch Neurol, 43, 1058, 10.1001/archneur.1986.00520100062016

Grilli, 2000, Proc Natl Acad Sci USA, 97, 12822, 10.1073/pnas.97.23.12822

Guo, 1999, Nat Med, 5, 101, 10.1038/4789

Harris, 1995, Neuroreport, 6, 1875, 10.1097/00001756-199510020-00013

Harris, 1996, J Neurochem, 67, 277, 10.1046/j.1471-4159.1996.67010277.x

Hensley, 1997, Int Rev Neurobiol, 40, 299, 10.1016/S0074-7742(08)60725-4

Ikonomovic, 1999, Exp Neurol, 160, 194, 10.1006/exnr.1999.7196

Klegeris, 1997, J Neurosci Res, 49, 229, 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W

Koh, 1990, Brain Res, 533, 315, 10.1016/0006-8993(90)91355-K

Kornhuber, 1989, J Neural Transm, 77, 231, 10.1007/BF01248936

Lees, 1993, Neuroscience, 54, 287, 10.1016/0306-4522(93)90254-D

Li, 1997, J Neuropathol Exp Neurol, 56, 901, 10.1097/00005072-199708000-00008

Lipton, 1994, N Engl J Med, 330, 613, 10.1056/NEJM199403033300907

Lukoyanov, 2001, Neurosci Lett, 309, 45, 10.1016/S0304-3940(01)02037-7

Masliah, 1996, Ann Neurol, 40, 759, 10.1002/ana.410400512

Masliah, 1998, J Neuropathol Exp Neurol, 57, 1041, 10.1097/00005072-199811000-00007

Mattson, 1992, J Neurosci, 12, 376, 10.1523/JNEUROSCI.12-02-00376.1992

Mattson, 2000, J Neurosci, 20, 1358, 10.1523/JNEUROSCI.20-04-01358.2000

Miguel-Hidalgo, 2002, Brain Res, 958, 210, 10.1016/S0006-8993(02)03731-9

Misztal, 1996, Eur J Pharmacol, 296, 1, 10.1016/0014-2999(95)00682-6

Moechars, 1999, J Biol Chem, 274, 6483, 10.1074/jbc.274.10.6483

Moechars, 1996, EMBO J, 15, 1265, 10.1002/j.1460-2075.1996.tb00468.x

Noda, 1999, Neuroscience, 92, 1465, 10.1016/S0306-4522(99)00036-6

Parsons, 1999, Neuropharmacol, 38, 735, 10.1016/S0028-3908(99)00019-2

Parsons, 1993, Neuropharmacol, 32, 1337, 10.1016/0028-3908(93)90029-3

Pearson, 1985, Proc Natl Acad Sci USA, 82, 4531, 10.1073/pnas.82.13.4531

Reisberg, 2003, N Engl J Med, 348, 1333, 10.1056/NEJMoa013128

Rogers, 1985, J Neurosci, 5, 2801, 10.1523/JNEUROSCI.05-10-02801.1985

Schneider, 2001, J Biol Chem, 276, 11539, 10.1074/jbc.M010977200

Stieg, 1999, Eur J Pharmacol, 375, 115, 10.1016/S0014-2999(99)00214-9

Wenk, 1994, Brain Res, 655, 7, 10.1016/0006-8993(94)91590-3

Wenk, 1995, Eur J Pharmac Env Tox Pharmacol, 293, 267, 10.1016/0926-6917(95)00028-3

Wenk, 1996, Neuroreport, 7, 1453, 10.1097/00001756-199606170-00001

Willard, 2000, Exp Brain Res, 134, 58, 10.1007/s002210000446

Winblad, 1999, Int J Geriatr Psychiatry, 14, 135, 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0

Zajaczkowski, 1997, Neuropharmacol, 36, 961, 10.1016/S0028-3908(97)00070-1

Zajaczkowski, 1996, Eur J Pharmacol, 296, 239, 10.1016/0014-2999(95)00716-4